Pawlicka M, Gumbarewicz E, Blaszczak E, Stepulak A
Cancers (Basel). 2024; 16(7).
PMID: 38611032
PMC: 11010970.
DOI: 10.3390/cancers16071354.
Li C, Tan X, Wei W, Li M, Zhang W, Gong Z
Rep Pract Oncol Radiother. 2024; 28(6):809-822.
PMID: 38515813
PMC: 10954264.
DOI: 10.5603/rpor.99355.
Li C, Gong Z, Zhang W, Zhang Y, Zhao H
Oral Maxillofac Surg. 2023; 28(2):547-555.
PMID: 37935817
DOI: 10.1007/s10006-023-01189-9.
Mastronikolis N, Kyrodimos E, Spyropoulou D, Delides A, Giotakis E, Piperigkou Z
Cancers (Basel). 2023; 15(7).
PMID: 37046817
PMC: 10093122.
DOI: 10.3390/cancers15072156.
Liang L, Kaufmann A
Int J Mol Sci. 2023; 24(3).
PMID: 36768876
PMC: 9917228.
DOI: 10.3390/ijms24032555.
Tumor-stroma ratio can predict lymph-node metastasis in cT1/2N0 oral tongue squamous cell carcinoma independent of tumor budding grade.
Sakai T, Saito Y, Tateishi Y, Yamazawa S, Fukuoka O, Kobayashi K
Int J Clin Oncol. 2022; 27(12):1818-1827.
PMID: 36197545
DOI: 10.1007/s10147-022-02249-y.
A transcriptomic map of EGFR-induced epithelial-to-mesenchymal transition identifies prognostic and therapeutic targets for head and neck cancer.
Schinke H, Shi E, Lin Z, Quadt T, Kranz G, Zhou J
Mol Cancer. 2022; 21(1):178.
PMID: 36076232
PMC: 9454230.
DOI: 10.1186/s12943-022-01646-1.
The Emerging Impact of Tumor Budding in Oral Squamous Cell Carcinoma: Main Issues and Clinical Relevance of a New Prognostic Marker.
Togni L, Caponio V, Zerman N, Troiano G, Zhurakivska K, Lo Muzio L
Cancers (Basel). 2022; 14(15).
PMID: 35892830
PMC: 9332070.
DOI: 10.3390/cancers14153571.
Tumor Cell Plasticity in Equine Papillomavirus-Positive Versus-Negative Squamous Cell Carcinoma of the Head and Neck.
Strohmayer C, Klang A, Kummer S, Walter I, Jindra C, Weissenbacher-Lang C
Pathogens. 2022; 11(2).
PMID: 35215208
PMC: 8875230.
DOI: 10.3390/pathogens11020266.
Cytoplasmic eIF6 promotes OSCC malignant behavior through AKT pathway.
Zhao Z, Chu W, Zheng Y, Wang C, Yang Y, Xu T
Cell Commun Signal. 2021; 19(1):121.
PMID: 34922580
PMC: 8684100.
DOI: 10.1186/s12964-021-00800-4.
Differences in Extracellular Vesicle Protein Cargo Are Dependent on Head and Neck Squamous Cell Carcinoma Cell of Origin and Human Papillomavirus Status.
Goudsmit C, Veiga Leprevost F, Basrur V, Peters L, Nesvizhskii A, Walline H
Cancers (Basel). 2021; 13(15).
PMID: 34359613
PMC: 8345072.
DOI: 10.3390/cancers13153714.
LINC00461 facilitates HNSCC development and reduces chemosensitivity by impairing miR-195-mediated inhibition of HOXA10.
Guan Y, Guan A, Chen L, Gong A
Mol Ther Oncolytics. 2021; 21:74-86.
PMID: 33869744
PMC: 8027536.
DOI: 10.1016/j.omto.2021.01.008.
Overexpression of ATAD2 indicates Poor Prognosis in Oral Squamous Cell Carcinoma.
Wang X, Wang S, Wu Z, Yang Q, Li H, Xiong H
Int J Med Sci. 2020; 17(11):1598-1609.
PMID: 32669963
PMC: 7359390.
DOI: 10.7150/ijms.46809.
CMTM6 promotes cell proliferation and invasion in oral squamous cell carcinoma by interacting with NRP1.
Zheng Y, Wang C, Song A, Jiang F, Zhou J, Li G
Am J Cancer Res. 2020; 10(6):1691-1709.
PMID: 32642284
PMC: 7339282.
Cellulose Mediated Transferrin Nanocages for Enumeration of Circulating Tumor Cells for Head and Neck Cancer.
Hazra R, Kale N, Aland G, Qayyumi B, Mitra D, Jiang L
Sci Rep. 2020; 10(1):10010.
PMID: 32561829
PMC: 7305211.
DOI: 10.1038/s41598-020-66625-2.
[Preliminary Study on Detection of Circulating Tumor Cells in Lung Cancer by EGFR/Vimentin/Folic Acid Magnetic Sphere].
Li G, Wang Y, Tan G, Liu Y, Xu Z, Feng H
Zhongguo Fei Ai Za Zhi. 2020; 23(5):351-359.
PMID: 32336066
PMC: 7260381.
DOI: 10.3779/j.issn.1009-3419.2020.103.05.
Biological Determinants of Chemo-Radiotherapy Response in HPV-Negative Head and Neck Cancer: A Multicentric External Validation.
van der Heijden M, Essers P, de Jong M, de Roest R, Sanduleanu S, Verhagen C
Front Oncol. 2020; 9:1470.
PMID: 31998639
PMC: 6966332.
DOI: 10.3389/fonc.2019.01470.
JUB induces epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway in hepatocellular carcinoma cells.
Wang H, Wang J, Shi X, Ding Y
Int J Clin Exp Pathol. 2020; 11(3):1374-1382.
PMID: 31938233
PMC: 6958140.
Thrombosis Risk Associated with Head and Neck Cancer: A Review.
Haen P, Mege D, Crescence L, Dignat-George F, Dubois C, Panicot-Dubois L
Int J Mol Sci. 2019; 20(11).
PMID: 31212608
PMC: 6600456.
DOI: 10.3390/ijms20112838.
CUL4B promotes aggressive phenotypes of HNSCC via the activation of the Wnt/β-catenin signaling pathway.
Wang Y, Yue D
Cancer Med. 2019; 8(5):2278-2287.
PMID: 30883036
PMC: 6536945.
DOI: 10.1002/cam4.1960.